Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Shen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Vaccine|January 15, 2019
Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccinationAngela Shen, Olga Khavjou, Grant King, et al.
Dermatology Online Journal|April 2, 2009
Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist?Gunjan M Modi, Angela Shen, Ali Mazloom, et al.
Scientific Reports|August 12, 2025
Association between placental epigenetic age acceleration and early postnatal growth patternsPriyadarshni Patel, Angela Shen, Cynthia Perez, et al.
Dermatology Online Journal|March 6, 2008
Dermatology misnomersNeda Nosrati, Mandy S Harting, Deborah J Yang, et al.
Journal of Occupational and Environmental Medicine|March 13, 2012
Post-hire asthma among insect-rearing workersEva Suarthana, Angela Shen, Paul K Henneberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II studyAnas Younes, Anna Sureda, Dina Ben-Yehuda, et al.
Investigational New Drugs|July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2018
Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviorsLuisa L Scott, James J Sahn, Antonio Ferragud, et al.
Blood Advances|April 25, 2022
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myelomaMatthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Vaccine|January 15, 2019
Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccinationAngela Shen, Olga Khavjou, Grant King, et al.
Dermatology Online Journal|April 2, 2009
Lupus erythematosus masquerading as erythema multiforme: does Rowell syndrome really exist?Gunjan M Modi, Angela Shen, Ali Mazloom, et al.
Scientific Reports|August 12, 2025
Association between placental epigenetic age acceleration and early postnatal growth patternsPriyadarshni Patel, Angela Shen, Cynthia Perez, et al.
Dermatology Online Journal|March 6, 2008
Dermatology misnomersNeda Nosrati, Mandy S Harting, Deborah J Yang, et al.
Journal of Occupational and Environmental Medicine|March 13, 2012
Post-hire asthma among insect-rearing workersEva Suarthana, Angela Shen, Paul K Henneberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II studyAnas Younes, Anna Sureda, Dina Ben-Yehuda, et al.
Investigational New Drugs|July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2018
Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviorsLuisa L Scott, James J Sahn, Antonio Ferragud, et al.
Blood Advances|April 25, 2022
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myelomaMatthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Pageof 3